@dansfera: A groundbreaking shift is happening in the fight against Duchenne Muscular Dystrophy. For years, young boys diagnosed with this devastating genetic condition have faced not only muscle wasting but the brutal side effects of traditional long-term steroid treatments. Now, a new next-gen steroid known as Agamri is entering the arena, designed to tackle inflammation and protect muscle cells without the harsh, debilitating drawbacks of previous therapies. It’s a massive step forward in pharmaceutical innovation and a glimmer of hope for families navigating the challenges of DMD. #DuchenneMuscularDystrophy #DMD #PharmaNews #RareDisease #MedicalBreakthrough